tiprankstipranks
Regulus completes enrollment in fourth cohort of Phase 1b kidney disease trial
PremiumThe FlyRegulus completes enrollment in fourth cohort of Phase 1b kidney disease trial
2M ago
Regulus reports Q2 EPS (17c), consensus (15c)
Premium
The Fly
Regulus reports Q2 EPS (17c), consensus (15c)
4M ago
RGLS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RGLS Upcoming Earnings Report: What to Expect?
4M ago
Regulus price target raised to $10 from $9 at H.C. Wainwright
PremiumThe FlyRegulus price target raised to $10 from $9 at H.C. Wainwright
5M ago
Regulus selloff on data an overreaction, says JonesResearch
Premium
The Fly
Regulus selloff on data an overreaction, says JonesResearch
5M ago
Regulus announces ‘positive’ data from clinical trial of RGLS8429
Premium
The Fly
Regulus announces ‘positive’ data from clinical trial of RGLS8429
5M ago
Regulus reports Q1 EPS (29c), consensus (22c)
PremiumThe FlyRegulus reports Q1 EPS (29c), consensus (22c)
7M ago
Is RGLS a Buy, Before Earnings?
Premium
Pre-Earnings
Is RGLS a Buy, Before Earnings?
7M ago
Regulus’ Phase 1b trial of ADPKD candidate advances to Cohort 4
Premium
The Fly
Regulus’ Phase 1b trial of ADPKD candidate advances to Cohort 4
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100